70
Participants
Start Date
February 17, 2023
Primary Completion Date
August 2, 2024
Study Completion Date
August 2, 2024
Antibiotics
Participants will be provided either nitrofurantoin 100 mg oral twice a day for 5 days, trimethoprim/sulfamethoxazole 875/125 oral twice a day for 3 days, fosfomycin 3g once oral, ciprofloxacin 250 mg oral twice a day for 5 days or cephalexin 500 mg oral twice a day for 5 days
Magee Women's Hospital of UPMC, Pittsburgh
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NIH
Megan Bradley
OTHER